LNC-Pcdh9-13:1 Is a Hypersensitive and Specific Biomarker for Early Hepatocellular Carcinoma

EBioMedicine - Netherlands
doi 10.1016/j.ebiom.2018.06.026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Oncogenic Wnt3a: A Promising Specific Biomarker in Hepatocellular Carcinoma

Hepatoma Research
2018English

Histamine Is a Helpful Novel Serological Biomarker for Experimental Hepatocellular Carcinoma

Bulletin of Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2016English

Plasma Osteopontin as a Novel Diagnostic Biomarker for Early Detection of Hepatocellular Carcinoma.

International Journal of Advanced Research
2017English

Models of Hepatocellular Carcinoma and Biomarker Strategy

Cancers
Cancer ResearchOncology
2010English

Des-Gamma-Carboxyprothrombin Is a Favorable Biomarker for the Early Diagnosis of Alfa-Fetoprotein-Negative Hepatitis B Virus-Related Hepatocellular Carcinoma

Journal of International Medical Research
BiochemistryMedicineCell Biology
2020English

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Deregulation of the Histone Lysine-Specific Demethylase 1 Is Involved in Human Hepatocellular Carcinoma

Biomolecules
BiochemistryMolecular Biology
2019English

DNA Methylation: Potential Biomarker in Hepatocellular Carcinoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2014English

Hepatic miR-126 Is a Potential Plasma Biomarker for Detection of Hepatitis B Virus Infected Hepatocellular Carcinoma

International Journal of Cancer
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy